(Q45174160)

10 December 2017

title

Targeted disruption of ErbB2/Neu in the mammary epithelium results in impaired ductal outgrowth (English)

1 reference

10 December 2017

1

1 reference

10 December 2017

Donald White

2

1 reference

10 December 2017

William J Muller

series ordinal

3

1 reference

10 December 2017

language of work or name

English

0 references

publication date

1 January 2005

1 reference

10 December 2017

1 reference

10 December 2017

volume

24

1 reference

10 December 2017

issue

5

1 reference

10 December 2017

page(s)

932-937

1 reference

ErbB2 is required for muscle spindle and myoblast cell survival.

10 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208230

Amplification of the neu/erbB-2 oncogene in a mouse model of mammary tumorigenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208230

Stochastic appearance of mammary tumors in transgenic mice carrying the MMTV/c-neu oncogene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208230

Regulation of genomic imprinting by gametic and embryonic processes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208230

A mutation in the epidermal growth factor receptor in waved-2 mice has a profound effect on receptor biochemistry that results in impaired lactation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208230

The crystal structure of a truncated ErbB2 ectodomain reveals an active conformation, poised to interact with other ErbB receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208230

Activated neu induces rapid tumor progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208230

Expression of dominant-negative ErbB2 in the mammary gland of transgenic mice reveals a role in lobuloalveolar development and lactation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208230

ErbB4 signaling in the mammary gland is required for lobuloalveolar development and Stat5 activation during lactation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208230

Requirement for neuregulin receptor erbB2 in neural and cardiac development

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208230

Impaired differentiation and lactational failure of Erbb4-deficient mammary glands identify ERBB4 as an obligate mediator of STAT5.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208230

Ductal growth is impeded in mammary glands of C-neu transgenic mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208230

Single-step induction of mammary adenocarcinoma in transgenic mice bearing the activated c-neu oncogene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208230

Elevated expression of activated forms of Neu/ErbB-2 and ErbB-3 are involved in the induction of mammary tumors in transgenic mice: implications for human breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208230

Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208230

Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208230

Generalized lacZ expression with the ROSA26 Cre reporter strain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208230

MMTV promoter hypomethylation is linked to spontaneous and MNU associated c-neu expression and mammary carcinogenesis in MMTV c-neu transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208230

neu/erbB-2 amplification identifies a poor-prognosis group of women with node-negative breast cancer. Toronto Breast Cancer Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208230

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/SJ.ONC.1208230

1 reference

Dimensions Publication ID

10 December 2017

1042223686

0 references

1 reference